217 related articles for article (PubMed ID: 30827270)
1. An HHV-8 Positive HIV Negative Multicentric Castleman's Disease, who Responded well to Rituximab Alone.
Kounatidis D; Rontogianni D; Sampaziotis D; Vardaka M; Giatra C; Dolapsakis C; Margellou E; Vallianou NG
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):84-86. PubMed ID: 30827270
[TBL] [Abstract][Full Text] [Related]
2. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multicentric Castleman’s disease in HIV-1 infected and uninfected patients: a systematic review.
Rokx C; Rijnders BJ; van Laar JA
Neth J Med; 2015 Jun; 73(5):202-10. PubMed ID: 26087799
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.
Speicher DJ; Sehu MM; Mollee P; Shen L; Johnson NW; Faoagali JL
Am J Transplant; 2014 May; 14(5):1207-13. PubMed ID: 24674650
[TBL] [Abstract][Full Text] [Related]
5. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
[TBL] [Abstract][Full Text] [Related]
6. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
7. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Kantarci FE; Eren R; Gündoğan C; Huq GE; Doğu MH; Suyanı E
J Infect Chemother; 2016 Jul; 22(7):483-5. PubMed ID: 26948831
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
[TBL] [Abstract][Full Text] [Related]
9. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
11. HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease.
Suda T; Katano H; Delsol G; Kakiuchi C; Nakamura T; Shiota M; Sata T; Higashihara M; Mori S
Pathol Int; 2001 Sep; 51(9):671-9. PubMed ID: 11696169
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease.
Bélec L; Mohamed AS; Authier FJ; Hallouin MC; Soe AM; Cotigny S; Gaulard P; Gherardi RK
Blood; 1999 Jun; 93(11):3643-53. PubMed ID: 10339470
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
[TBL] [Abstract][Full Text] [Related]
14. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient.
Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I
Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666
[TBL] [Abstract][Full Text] [Related]
15. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
Casper C; Nichols WG; Huang ML; Corey L; Wald A
Blood; 2004 Mar; 103(5):1632-4. PubMed ID: 14615380
[TBL] [Abstract][Full Text] [Related]
16. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
Fernando I; Scott G
Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
[TBL] [Abstract][Full Text] [Related]
17. The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.
Stebbing J; Ngan S; Ibrahim H; Charles P; Nelson M; Kelleher P; Naresh KN; Bower M
Clin Exp Immunol; 2008 Dec; 154(3):399-405. PubMed ID: 19222502
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 8-related Castleman disease in the absence of HIV infection.
Dossier A; Meignin V; Fieschi C; Boutboul D; Oksenhendler E; Galicier L
Clin Infect Dis; 2013 Mar; 56(6):833-42. PubMed ID: 23223599
[TBL] [Abstract][Full Text] [Related]
19. Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.
Anderson S; Sasson SC; Lee FJ; Cooper W; Larsen S; Garsia R
BMC Infect Dis; 2016 Feb; 16():53. PubMed ID: 26831502
[TBL] [Abstract][Full Text] [Related]
20. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.
Fajgenbaum DC; van Rhee F; Nabel CS
Blood; 2014 May; 123(19):2924-33. PubMed ID: 24622327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
